Targeting glutamate: the end of the monoamine hypothesis?
December 5, 2012A number of recent papers have focused attention on the remarkable responses seen with glutamatergic agents in major depressive disorder (MDD), raising questions about the monoamine hypothesis of psychiatric disorders that has dominated biological psychiatry for a half century (Schildkraut JJ. Am J Psychiatry 1965;122:509-522). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you reg…